Injecting within 48 hours of your previous dose significantly increases the risk of gastrointestinal adverse events and provides no therapeutic benefit
The extent of these molecules efficacy and safety in the context of sunless tanning remains less established
Genistein administration induced Nrf2 enhancement by activation/phosphorylation of keap1, sirt1, MAPK-ERK1/2, PKC, and estrogen receptor in other cells or tissues, such as: hippocampal tissue, hypothalamic paraventricular nucleus, ovary, and Caco-2 cells [131, 135,136,137]
Patients should be aware of symptoms requiring urgent medical attention while abroad, including severe abdominal pain, persistent vomiting, signs of dehydration, or symptoms of pancreatitis or gallbladder disease